Find in Library

To the Editor, During the first few months of 2020, a severe acute respiratory syndrome outbreak due to coronavirus 2 (SARS-CoV-2) was an- nounced worldwide. The WHO (World Health Organization) declared the global pandemic in March 11, 2020. After the United States, to this day Spain remains as the second country with the highest number of patients infected. Apart from the direct consequences of the coronavirus disease 2019 (COVID-19), the healthcare system overload is negatively impacting the effective management of other severe conditions whose treatment can’t wait. During the current COVID-19 pandemic, patients with cardiovascular diseases are suffering diagnostic and treatment delays that are probably impacting cardiovascular mortality.1 Scientific societies have issued several warnings on the management of the acute coronary syndrome and ST-segment elevation myocardial infarction.2